查阅中文 language

About Jie

Jie Zhang’s practice focuses on advising corporate clients and investment banks on capital markets transactions, such as initial public offerings, follow-on offerings, and convertible bond offerings. She also advises corporate and private equity clients on mergers and acquisitions, private equity financings and privatizations. In addition, Jie represents clients listed in the U.S. and Hong Kong on general corporate and securities regulatory compliance matters.

View full bio

Experience

Butong Group Announces HK$781.84 Million IPO

Butong Group Announces HK$781.84 Million IPO

September 23, 2025

Cooley advised Butong Group in connection with its HK$781.84 million initial public offering (IPO).

Read more

Related contacts

Will Cai
Partner, Hong Kong
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Jie Zhang
Counsel, Hong Kong
Dichun Duan
Associate, Beijing
Tonny Yu
Associate, Hong Kong
Karen Tsai
Special Counsel, Washington, DC
Brian Lau
Associate, Hong Kong
Juan Nascimbene
Associate, London
Zhengyang Li
International Legal Project Manager, Hong Kong
Blake Cao
Senior Legal Assistant, Beijing
Philip Kwan
Senior Legal Assistant, Hong Kong

Related Practices & Industries

Capital Markets
Asia
Retail and Consumer Products
CFIUS

Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion

Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion

December 26, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Izzy Lubarsky
Partner, New York
Brittany K. Wightman
Associate, San Diego
Rajdeep Roger Bains
Associate, San Diego
Will Cai
Partner, Hong Kong
Patrick Loofbourrow
Partner, Singapore
Jie Zhang
Counsel, Hong Kong
Hilda Li
Associate, Hong Kong
Alessandra Murata
Partner, Palo Alto
Charity Williams
Partner, San Diego
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Rena Kaminsky
Special Counsel, Palo Alto
Stella Sarma
Partner, Brussels
Andrew Epstein
Special Counsel, Seattle
Dillon Martinson
Special Counsel, Washington, DC
Patrick Sharma
Associate, Santa Monica
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles
Sarah Oliai
Associate, Washington, DC

Related Practices & Industries

Mergers and Acquisitions
Biotechnology
Healthcare
Asia
Capital Markets
Compensation and Benefits
Life Sciences Corporate Partnering and Licensing
Tax
Antitrust and Competition
Labor and Employment
CFIUS
Cyber/Data/Privacy

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors

August 9, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, on its private placement financing of up to $150 million.

Read more

Related contacts

Will Cai
Partner, Hong Kong
Jie Zhang
Counsel, Hong Kong
Francis Wheeler
Senior Counsel, Colorado
Hilda Li
Associate, Hong Kong
Harvey Yao
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong

Related Practices & Industries

Capital Markets
Life Sciences
Asia

Structure Therapeutics – $185.3 Million IPO

Structure Therapeutics – $185.3 Million IPO

February 9, 2023

San Francisco – February 9, 2023 – Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Related contacts

Charlie Kim
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Andrew Harline
Partner in Charge – Singapore, Singapore
Su Lian Lu
Special Counsel, Santa Monica
Xander Lee
Partner, Santa Monica
Jie Zhang
Counsel, Hong Kong
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Carlos Ramirez
Partner, San Diego
Ryan Blair
Partner, San Diego
Joshua Mates
Partner, San Francisco
Mark Ballantyne
Partner, Reston
Nicola Squire
Partner, London
Francis Wheeler
Senior Counsel, Colorado
Will Cai
Partner, Hong Kong
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Randy Sabett
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Lisa Yuan
Special Counsel, Beijing
Christine Turner
Associate, Colorado
Vince Flynn
Associate, San Diego
Ivy Wang
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Cara Buchicchio
Associate, New York
Megan Drill
Associate, San Diego
Cristina Ferruolo
Associate, San Diego
Brian Lau
Associate, Hong Kong
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Lunga Su
Associate, Shanghai
Christine S. Kim
Associate, San Diego
Andy Zachrich
Associate, San Francisco

Related Practices & Industries

Capital Markets
Emerging Companies
Venture Capital
Biotechnology
Life Sciences
Healthcare
Tax
Commercial Litigation
Labor and Employment
Compensation and Benefits
Cyber/Data/Privacy
Export Controls and Economic Sanctions

TI Cloud – $71.7 Million IPO

TI Cloud – $71.7 Million IPO

July 27, 2022

Cooley advised TI Cloud on its $71.7 million initial public offering of 43,530,000 shares at a public offering price of HK$12.85 per share. TI Cloud offers a broad array of cloud-native customer contact solutions that enable enterprises to engage in multichannel customer interactions. Partners Michael Yu and Will Cai led the Cooley team.

Related contacts

Philip Kwan
Senior Legal Assistant, Hong Kong
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Brian Lau
Associate, Hong Kong
Jie Zhang
Counsel, Hong Kong
Ying Liu
Associate, Hong Kong
Will Cai
Partner, Hong Kong

Related Practices & Industries

Capital Markets
Technology
View more

Admissions and credentials

New York

Hong Kong (Registered Foreign Lawyer)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.